Molecular and Clinical Characteristics of Different Toxicity Rates in Anti-CD19 Chimeric Antigen Receptor T Cells: Real-World ExperienceEleni Gavriilaki, Ioanna Sakellari, Ioannis Batsis et al.|Cancers|2023Cited by 6
Evaluation of Cognitive Impairment and Neurotoxicity Post CAR-T Cell Therapy.Evlampia Strongyli, Ioanna Sakellari, Eleni Gavriilaki et al.|Transplantation and Cellular Therapy|2025Cited by 0
Longitudinal Cognitive Assessment After CAR-T Cell Immunotherapy: A Prospective Cohort StudyEvlampia Strongyli, E Gavriilaki, Anna Papakonstantinou et al.|Cancers|2026Cited by 0